Research Groups and R&D Platforms: Biomarker

Research Group:
Biomedical Epigenomics

Riikka Lund
riikka.lund[at]utu.fi

Biomedical Epigenomics Group,
Turku Bioscience,

University of Turku

Riikka Lund

Biomedical Epigenomics

Ageing-related diseases, Basic research, Biomarker, Biomedicine, Biotechnology, Data mining, Diagnostics, Disease models, Drug target, Epigenomics, Genetics, Genomics, Imaging, Molecular Biology, Molecular Cell Biology, Molecular diagnostics, Next-generation sequencing, Personalized medicine, Target discovery

Research Group:
Systems Medicine

Matej Oresic
matej.oresic[at]utu.fi

Turku Bioscience,
University of Turku

Matej Oresic

Systems Medicine

Assay development, Autoimmune diseases, Bioinformatics, Biomarker, Diabetes, Diagnostics, Metabolic diseases, Metabolomics, Molecular diagnostics, Obesity, Personalized medicine, Systems Biology

Research Group:
The in vitro/in vivo applications of hot electrons in clinical research and health care

Heikki Peuravuori
heipeu[at]utu.fi

Institute of Biomedicine,
University of Turku

Heikki Peuravuori

Antibacterial, Antibodies, Assay development, Bacteriology, Biochemistry, Biomarker, Biomedicine, Biotechnology, Chemical Physics, Clinical Chemistry, Electron microscopy, Fluorescence spectroscopy, Imaging software, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Medicinal chemistry, Point of care

Research Group:
Cell fate – from molecular understanding to control

Cecilia Sahlgren
cecilia.sahlgren[at]abo.fi, cecilia.sahlgren[at]bioscience.fi

Turku Bioscience and
Faculty of Science and Engineering,
Åbo Aakdemi University

Cecilia Sahlgren

Cell fate

The Cell Fate Lab

Atomic-force microscopy, Basic research, Biochemistry, Biomarker, Biotechnology, Breast cancer, Cancer, Cardiovascular diseases, Data mining, Developmental disorders, Diagnostics, Disease models, Drug delivery, Drug target, Imaging, Imaging software, In Vivo Diagnostics, Molecular Cell Biology, Molecular modelling, Personalized medicine, PET, Proteomics, Receptor, Signaling, Super-resolution imaging, Target discovery

Research Group:
Molecular imaging of atherosclerosis and heart failure

Antti Saraste
antti.saraste[at]utu.fi

Heart Center and PET Center,
University of Turku

Antti Saraste

Basic research, Biomarker, Cardiovascular diseases, Clinical Medicine, Diabetes, Disease models, Imaging, In Vivo Diagnostics, Inflammation, PET, Target discovery, Ultrasound imaging

Research Group:
Alpha2-Adrenoceptors as targets for drug development

Mika Scheinin
mschein[at]utu.fi

University of Turku, Turku University Hospital and CRST Oy

Mika Scheinin

Clinical Research Services Turku

Ageing-related diseases, Allergy, Antibodies, Assay development, Asthma, Autoimmune diseases, Basic research, Biomarker, Biomedicine, Biopharmaceuticals, Cancer, Cardiovascular diseases, Clinical Medicine, Diabetes, Diagnostics, Disease models, Drug delivery, Drug target, Endocrinology, Imaging, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Medicinal chemistry, Metabolic diseases, Metal disorders, Molecular diagnostics, Musculoskeletal disorders, Natural products, Neurological disorders, Obesity, Organic compounds, Personalized medicine, PET, Pharmacology, Receptor, Screening, Signaling, Skin diseases, Target discovery